Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Cognitive Protocol

CerlutenComplete Dosing & Administration Guide

Brain-derived peptide bioregulator complex containing AED, KED, AEDG, and KE peptides that promote neurogenesis through histone binding, restore dendritic spine architecture under neurotoxic conditions, and enhance cognitive recovery in stroke and brain injury patients

Dose Range

10-20mg

Frequency

Once daily

Route

Oral (capsule)

Cycle Length

8-12 weeks

Dosing

How much
do I take?

Starting Dose

1 capsule (10-20 mg) once daily OR 5-6 sublingual drops 3 times daily

Frequency

Capsule: once daily morning; Drops: 3-4 times daily

Duration

10-14 days initial assessment

Begin with the standard starting protocol. Capsules are taken before breakfast with water. Sublingual drops (0.25-0.35 mL per dose) are held under the tongue for 1-2 minutes before swallowing, 10-15 minutes before eating. The sublingual form provides faster absorption and bypasses first-pass metabolism. Effects are gradual — allow the full initial period before assessing response.

Standard Dose

1-2 capsules daily OR 5-6 drops 3-4 times daily

Frequency

Capsule: 1-2 times daily; Drops: 3-4 times daily

Duration

20-30 days per treatment course

Standard clinical protocol for cognitive support and post-stroke recovery. In Russian clinical studies, 1-2 capsules were given 2-3 times daily for 10-20 days with significant EEG and cognitive improvements. Repeat courses every 3-6 months. Can be combined with Pinealon for serotonin/melatonin support or Epithalon for neuroendocrine support. Track cognitive changes using standardized assessments if possible.

Advanced Dose

2 capsules 2-3 times daily

Frequency

2-3 times daily

Duration

10-20 days per course

Clinical trial protocol used in the 48-patient CNS disease study at the Saint Petersburg Institute. This higher-frequency regimen produced significant improvements (64.6% of patients) and EEG normalization. Typically reserved for structured clinical protocols under medical supervision. Often combined with other Khavinson bioregulators: Endoluten for neuroendocrine support, Vladonix for immune function, Sigumir for musculoskeletal, Svetinorm for liver, and Ventfort for vasculature.

Timing

Best time to take

Take Cerluten at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.

With food?

Cerluten can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.

If stacking

Cerluten should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

  • +You've tolerated the current dose for the recommended period without significant side effects
  • +Therapeutic goals haven't been met at the current dose level
  • +Your healthcare provider recommends dose escalation based on your response
  • +Lab work or clinical assessments support a higher dose

Decrease if

  • -Side effects are bothersome or impacting daily life despite management strategies
  • -You experience any signs of an adverse reaction
  • -Lab results indicate the need for dose reduction
  • -Your healthcare provider recommends a lower dose based on your response

Signs of right dose

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Cerluten in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

Example

Cerluten comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Use Cerluten exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Injection

Route

Cerluten is administered Oral (capsule)—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

Technique

  • 1.Follow the specific administration instructions for your Cerluten formulation
  • 2.Take or apply as directed by your healthcare provider
  • 3.Store properly between uses according to package instructions

Storage

Before reconstitution

Store Cerluten in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Cerluten should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (once daily)

As prescribed by your healthcare provider injection

Site: Oral (capsule)—rotate sites if applicable

Maintain a consistent schedule for optimal results with Cerluten. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is it
safe?

Safety Profile

Cerluten is a peptide extract from cerebral tissue of young animals that is not FDA-approved and lacks rigorous clinical safety data. As an undefined mixture of peptides and proteins from animal sources, quality control and batch consistency cannot be guaranteed. Potential risks include allergic reactions to animal-derived proteins, contamination with microbial pathogens or prions, and unknown long-term immunological effects. No comprehensive safety studies have been conducted in humans, and the active pharmaceutical components have never been identified or standardized. The product exists primarily in Russian and Eastern European medical markets without Western regulatory oversight.

Evidence consists of traditional clinical use in Russian medicine spanning decades and a small number of observational studies, primarily published in non-English journals. No toxicology screening, animal safety studies by modern standards, human Phase 1 data, or randomized controlled trials exist. Published reports are mostly descriptive case series or open-label observations without proper controls or safety monitoring parameters.

Common Side Effects

Experienced by some users

Mild headache

Transient headache during the initial days of treatment as brain neurochemistry adjusts to enhanced neuronal gene expression and modified signaling patterns.

Management: Ensure adequate hydration. Usually self-limiting within 3-5 days. Reduce dose temporarily if persistent.

Mild drowsiness

Slight fatigue or drowsiness in the first few days, particularly with the sublingual form, as neuronal activity patterns shift.

Management: Take in the morning or early afternoon. Usually resolves within the first week of use.

Mild GI discomfort

Slight nausea or stomach discomfort with oral capsule administration, common with peptide supplements.

Management: Take capsules with a small amount of food or water. Consider the sublingual form to bypass the GI tract.

Vivid dreams

Enhanced dream vividness reflecting active neuroplasticity and neural reorganization processes stimulated by the peptide complex.

Management: Generally benign and may indicate active neurogenesis. No action typically required.

Less Common

  • Transient sleep pattern changes

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

  • ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • ×Your healthcare provider recommends discontinuation based on your clinical response
  • ×Development of any new medical condition that may be contraindicated with Cerluten
  • ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • ×Abnormal lab results or clinical markers that suggest adverse effects

Cerluten should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

  • May be used together under medical guidance.
  • May be used together under medical guidance.
  • May be used together under medical guidance.

With medications

  • !Other CNS-active peptide complexes at high doses without medical guidance — potential for overlapping epigenetic effects - Use with caution—discuss with your healthcare provider.
  • !Strong sedatives or CNS depressants — may produce additive sedation - Use with caution—discuss with your healthcare provider.
  • !Immunosuppressive medications — Cerluten's component peptides have immunomodulatory properties that may interact with immunosuppression - Use with caution—discuss with your healthcare provider.

With supplements

  • Multivitamins - Generally safe to take alongside Cerluten. Space doses apart if taking oral formulations to ensure optimal absorption.
  • Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Cerluten research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full Cerluten Profile

Medical Disclaimer

Cerluten is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026